Infertility Clinical Trials at CHR
CHR is committed to fertility research and education. As a leading fertility center focused with rigorous fertility research program, CHR is always conducting multiple fertility studies. Below are three current clinical trials for which we are actively recruiting participants. For a list of fertility research publications that came out as a result of CHR's research activities, please refer to our publications list.
Dr. Barad on CHR's Research
“Medicine, over time, progresses because somebody has an idea, somebody tries to implement that idea,” says the Center for Human Reproduction's Dr. David H. Barad
Currently Ongoing Clinical Trials
Clinical trials listed in this section are currently ongoing, and may be recruiting participants, although some trials are open by invitation only.
Clinical Trial NCT02179255: Open-Label Randomized Trial of Human Growth Hormone (HGH) for Enhancement of Ovulation Induction in Association with In Vitro Fertilization (IVF)
The purpose of this study is to determine whether administering human growth hormone during the early stages of follicle development improves ovarian response to stimulation with gonadotropins. Participation to this study will be offered to patients who have previously failed to respond to ovarian stimulation while on DHEA supplementation, or demonstrated less than 2 eggs after ovarian stimulation with DHEA.
Clinical Trial NCT01662466: Effect of Testosterone Supplementation vs Placebo on Embryo Quality among Women with Diminished Ovarian Reserve Undergoing IVF
The purpose of this study is to determine the effect of treatment with trans-dermal testosterone cream compared to placebo on measures of ovarian reserve, oocyte and embryo quality, and pregnancy rates among women with evidence of diminished ovarian reserve that have persistently low serum testosterone and free testosterone after completing six previous weeks of DHEA supplementation.
Closed Clinical Trials
Clinical trials listed in this section has been completed or closed. Results for completed studies will be published on a timely basis.
Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.